Trial Profile
Bevacizumab (Avastin) as an Adjunct to Vitrectomy in the Management of Severe Proliferative Diabetic Retinopathy: a Prospective Case Series.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2010
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions
- 09 Jan 2010 New trial record